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Background: Skin cancer has reached epidemic proportions, with more new cases diagnosed annually than the
combined incidence of cancers of the breast, prostate, lung, and colon. Estimates show 2 to 3 million new
cases of non-melanoma skin cancer (NMSC) every year, and, among women, it is the young (younger than 45
years) who are disproportionately affected.
Objective: This article aims to address questions and concerns pertinent to skin cancer in a woman-centric way.
An updated landscape of causative factors, the latest detection/treatment methods, and ultimately the preventa-
tive measures available to them are described.
Methods: A broad literature search was conducted using the PubMed database with search terms focusing on fe-
male gender. Additional articles were identiﬁed from cited references.
Conclusions: The published ﬁndings on causation of melanoma skin cancer and non-melanoma skin cancer in
females are outlined, as well as current detection methods and treatment options. Furthermore, a variety of
preventative measures speciﬁc to women that can reduce the chance of being diagnosed with skin cancer
are discussed.
© 2015 The Authors. Published by Elsevier Inc. on behalf ofWomen's Dermatologic Society. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Epidemiology
Skin cancer has reached epidemic proportions, withmore new cases
diagnosed annually than the combined incidence of cancers of the
breast, prostate, lung, and colon. Estimates show 2 to 3 million new
cases of non-melanoma skin cancer (NMSC) every year, and among
women, it is those younger than 45 yearswhoare disproportionately af-
fected. Furthermore, there are increasing rates of melanoma in women
before the age of 45 years (Simoes et al., 2015). Although diagnosis and
treatment of skin cancer has negative psychological effects to any indi-
vidual, studies show thatwomen are affectedmore thanmen, especially
young, single womenwho are particularly concerned about their health
and appearance during this time in their life (Giese-Davis et al., 2012).
High stress, poor quality of life, body image dissatisfaction, and fear
of recurrence are among the ramiﬁcations experienced by women
who receive a diagnosis of melanoma or non-melanoma skin cancer
(Al-Shakhli et al., 2006; Atkinson et al., 2013; Radiotis et al., 2014).
This report aims to address questions and concerns pertinent to skin
cancer in women. An updated landscape of causative factors, the latest
detection/treatment methods, and ultimately the preventative mea-
sures available are described.f interest.
S. Sadick).
er Inc. on behalf of Women's Der
).Causative factors
Multiple endogenous (fair skin, family history cancer, presence of
skin dysplasia, genetic background) and exogenous (exposure to ultra-
violet [UV] light, both intermittent and cumulative) factors are known
to confer skin cancer susceptibility. Melanoma risk is predominantly as-
sociated with sun exposure in early life, whereas NMSC is associated
with sun exposure in both adulthood and early life (Wu et al., 2014).
While white, pale skin used to be associatedwith afﬂuence and physical
health, at the turn of the 20th century, a newmedical paradigm focusing
on the therapeutic beneﬁts of sunlight, along with social and cultural
changes such as paid vacation, outdoor activities, and fashion trends, ig-
nited a shift in sun-exposure attitudes (Randle, 1997). Swimwear and
sportswear for women increased body exposure from 18% to 47%; the
invention of the bikini increased body exposure to almost 92% and tan
skin was promoted in women’s fashion media as highly desirable.
The surge in indoor tanning centers in the 1980s directly led to a dra-
matic increase of overall UV exposure. Themost frequent patrons, white
female adolescents of higher socioeconomic status, provided this popu-
lation with an additional source of UV radiation besides outdoor expo-
sure, and thus an increased risk of skin cancer (Hausauer et al., 2011).
Other lifestyle factors associated with skin cancer risk in women are
use of tobacco and alcohol, as research has shown smoking and high al-
cohol consumption, especially white wine and liquor, are related to
developing NMSC (Kubo et al., 2014; Rollison et al., 2012). Although itmatologic Society. This is an open access article under the CC BY-NC-ND license
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deodorants to creams andmakeup that come in contactwith awoman’s
skin, can pose a potential risk in the development of skin cancer. The
cosmetic industry uses thousands of synthetic chemicals, but the Food
and Drug Administration (FDA) only regulates the colors that can be
used in hair dyes. Some of the common constituents found in cosmetics,
such as parabens, benzophenone-3, and phthalates, are known endo-
crine disruptors and have been associated with the development of
breast cancer. Parabens can interact with estrogen receptors, potentiate
UV-induced damage, and have been suspected to lead to the develop-
ment of melanocytic lesions (Darbre and Harvey, 2008; Dewalque
et al., 2014).
Detection and treatment
Early detection of skin cancer unequivocally improves prognosis,
promotes survival, and reduces the burden of stressful treatment proce-
dures. Patients, through self-screening, can be the ﬁrst to detect suspi-
cious skin lesions (Rigel et al., 2010). As women pay particular
attention to the health of their skin, especially the face and extremities
that are the most common anatomical sites of skin cancer manifesta-
tion, they have a greater probability of self-detecting skin anomalies
(Chevalier et al., 2014; Lee et al., 2014). Women tend to be more open
and communicative about voicing their health concerns, and through-
out their lives tend to have more contact with health professionals.
Women frequent beauty salons more than men, where aestheticians,
hairstylists, and massage therapists may contribute to discovering skin
anomalies (Glithro et al., 2015). Women also are generally more
aware of the risk factors associatedwith skin cancer and proper sunpro-
tection guidelines, as shown by a recent survey conducted by the Na-
tional Skin Cancer Foundation (PR Newswire, 2012). This increased
awareness is coupled with the proper know-how when performing
self-examinations and searching for suspicious lesions.
Along with patient and physician screens, diagnostic technologies
have dramatically improved, facilitating early disease detection. The
gold standard of skin cancer diagnosis is biopsy followed by histopath-
ological examination (Simoes et al., 2015). The discomfort, potential
scarring, and invasiveness of this procedure are distressing, especially
for youngwomen. Dermatoscopy, total body photography (TBP), confo-
cal microscopy, multispectral devices (SIAscope, MelaFind), diagnostic
ultrasound, mRNA analysis of tape-stripped epidermal stages, and
even smartphone apps are few of the new non-invasive, painless tech-
nologies that may reduce unnecessary biopsies (Mayer et al., 2014).
The diagnostic efﬁcacy is still under study for most of these new tools,
and there are barriers to their adoption, such as cost, physician training,
and insurance coverage.
While eradicating the cancer is at the forefront of a woman’s expec-
tations during treatment, minimizing scarring and other aesthetic con-
cerns should be taken into consideration. Surgical modalities have
been the mainstay treatment option, with excision biopsy being the
gold standard (Simoes et al., 2015). Superﬁcial ablative techniques
such as electro-desiccation and curettage or cryotherapy are used pri-
marily for low-risk NMSC tumors, whereas full-thickness techniques
such as Mohs micrographic surgery, excision surgery, and radiotherapy
are used to treat high-risk NMSC tumors.
The standard of care for melanoma is surgical excision.Women pre-
senting with tumors on cosmetically critical sites, such as the lips, nose,
cheek, or eyelid regions, can be successfully treatedwith a new technol-
ogy based on a variation of Mohs surgery that provides the highest cure
rate and creates the smallest surgical defect. The procedure uses an anti-
melanoma targeted antibody known as MART-1 (melanoma antigen
recognized by T cells), which improves the speed and accuracy of the
procedure and allows the surgeon to microscopically identify and re-
move the melanoma cells with minimal sacriﬁce of healthy tissues in
real-time. The precision of this technique is critical when working on
delicate structures such as an eyelid (Lee et al., 2014).Common concerns amongwomen are how treatment of skin cancer
will interfere with family planning and even pregnancy, as many
women are delaying pregnancy until their 30s or 40s and the incidence
of skin cancer diagnosis during a woman’s child-bearing years has in-
creased (Melanoma and pregnancy, 2009). For thin, less than 1 mm,
early stage–type tumors, there is good prognosis with low cancer reoc-
currence, thus a woman does not need to delay getting pregnant. For
womanwith a history of a thicker skin tumors, the prognosis is unclear;
thus, they are advised to leave a 2 to 3 year gapbefore pregnancy, as that
is themost common time for the disease to recur (Peccatori et al., 2013;
Pentheroudakis et al., 2010). If diagnosis occurs during pregnancy, a
body of evidence based on six case-control studies and two large
population-based studies found that, apart from creating distress,
treating the disease is safe and does not pose any threat to the fetus,
with the exception of rare cases of advanced melanoma (Beccatori
et al.; Pentheroudakis et al.). Local excision of a tumor can be safely per-
formed under local anesthesia during pregnancywith concomitant fetal
monitoring; for thicker tumors, sentinel lymphnodemapping and biop-
sy should be considered (Davis et al., 2014).
The future of skin cancer treatment is also very promising, with inno-
vative minimally or non-invasive approaches emerging to address even
the most challenging of cases. Five drugs have gained FDA approval for
the treatment of advancedmelanoma,with approval of several others an-
ticipated in the near future (Lo and Fisher, 2014). Along with molecular
drug discovery, technological advances in the drug carrier system are un-
derway, which will permit a localized and controlled drug release while
ensuring minimal systemic damage and maximal sparing of healthy tis-
sue. Investigational strategies include nanoparticles, liposomes, cell-
penetrating peptides (CPPs), and stem cells (Simoes et al., 2015).Prevention methods
A variety of preventative measures speciﬁc to women can signiﬁ-
cantly reduce their chance of being diagnosed with skin cancer. Rigor-
ous use of broad-spectrum (UVA/UVB) sunscreen with an SPF of 15 or
higher, seeking the shade when outdoors, and protective clothing
should be incorporated as part of an everyday routine for both men
and women. Women are the biggest consumers of beauty products,
and although many brands integrate a built-in sun-protection factor in
their cosmetic products, it should be emphatically stressed that this can-
not substitute use of sunscreen because the sun-protection strength of
cosmetics is often considerably weaker. For women pursuing a “healthy
glow,” the American Academy of Dermatology recommends self-
tanning products as an alternative to tanning in UV light from the sun
or indoor tanning. Although the majority of women who tan are
aware that use of tanning beds poses an increased skin cancer risk,
they are still heavily used (Petit et al., 2014). Studies have demonstrated
that tanning beds have addictive potential and that women are more
likely to be addicted, with the greatest tendencies occurring among
white women younger than 50 years; psychological counseling and/or
medication interventions to address the reasons underlying this com-
pulsive behavior may be the best skin cancer preventative strategy in
these cases. Public measures can also halt the use and accessibility of in-
door tanning beds. Most states have some artiﬁcial tanning restrictions
in place for minors. Furthermore, the fashion world, too, has joined
these preventative efforts, as seen in the prohibition of tanning in
models in the 2012 Fashion Weeks in London, England, and New York,
New York (Chang et al., 2014).
Healthy lifestyle changes, such as limiting smoking and alcohol con-
sumption and following a diet that is rich in dietary antioxidants and
phytochemicals in the form of whole foods, particularly fruits and veg-
etables, has been associatedwith reduction of some forms of skin cancer
in women, and as such should be recommended as a preventative strat-
egy (Lo and Fisher, 2014). Supplementation of aspirin and vitamin D,
which was shown to signiﬁcantly counter the risk of skin cancer in
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et al., 2014; Petit et al., 2014).
Although skin is the most common site of cancer, its malignancies
are likely to be among the most preventable. Public and individual
health initiatives targeting skin cancer reduction are showing promising
positive results. According to the latest ﬁgures of the American Cancer
Society, despite the alarming rise of incidence rates over the past 30
years, trends appear to have plateaued in the younger women (Hery
et al., 2010). Health and ﬁtnessmagazines are a popular medium for in-
creasing exposure to health-related content, and as they are read
monthly bymillions of women of varied ages, they can adopt amore fo-
cused approach to informing women of skin cancer risks and relevant
preventive measures (Basch et al., 2014; Cho et al., 2010). The mobile
device revolution may also impact early detection and skin cancer pre-
vention (Buller et al., 2015).
Prevention of skin cancer by clinical providers who have frequent
surveillance opportunities with their female patients is a currently rec-
ognized practice gap. Time constraints during a patient–doctor visit and
lack of conﬁdence in the skin cancer examination are some of the bar-
riers, and initiatives such as integrating instructional ﬁlms during med-
ical training are currently being tested for efﬁciency (Garg et al., 2014).
Engagement of untapped resources in the community, such as beauty
providers and other medical practitioners such as chiropractors, can
also impact skin cancer prevention; initial data show that these pro-
viders are open and receptive to training to fulﬁll this role (Glithro
et al., 2015; Roosta et al., 2012). Encouraging a uniform,worldwide con-
sensus in prevention and early detection programs can further impact
disease eradication in women and reduce the need for invasive, poten-
tially disﬁguring procedures.References
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